Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMATI
NCT05138068Phase 2Completed
- Start
- Apr 2022
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in Social Anxiety Disorder (SAD). Started Apr 2022; status: completed.
02
Drugs
midomafetamine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT05138068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05138068.